Decreased expression of Beclin-1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma
The autophagy-related gene Beclin-1 is critical in the regulation of tumourigenesis and progression, but its role in oral tongue squamous cell carcinoma (OTSCC) has not yet been reported. This study aimed to investigate Beclin-1 expression and its significance in OTSCC. Beclin-1 expression was asses...
Main Authors: | , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
D.A. Spandidos
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940089/ |
id |
pubmed-4940089 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-49400892016-07-21 Decreased expression of Beclin-1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma Hu, Zedong Zhong, Zhaoming Huang, Shaohui Wen, Haojie Chen, Xue Chu, Hongying Li, Qiuli Sun, Chuanzheng Articles The autophagy-related gene Beclin-1 is critical in the regulation of tumourigenesis and progression, but its role in oral tongue squamous cell carcinoma (OTSCC) has not yet been reported. This study aimed to investigate Beclin-1 expression and its significance in OTSCC. Beclin-1 expression was assessed by reverse transcription-quantitative polymerase chain reaction or western blot analysis in 14 OTSCC tissues and matched adjacent noncancerous tissues as well as in 5 OTSCC cell lines and a normal tongue epithelial cell line. Beclin-1 protein expression was examined by immunohistochemistry in 133 OTSCC specimens, and the correlation between Beclin-1 expression and clinicopathological features was investigated. Furthermore, MTT and colony formation assays were performed to investigate the effect of Beclin-1 on the proliferation and clonogenicity of OTSCC cells. It was demonstrated that Beclin-1 expression was significantly decreased in the majority of the 14 OTSCC tissues and the 5 OTSCC cell lines relative to the matched non-cancerous tissues and the normal tongue epithelial cell line, respectively. Immunohistochemistry analysis revealed that decreased Beclin-1 expression was significantly correlated with poor differentiation, lymph node metastasis, advanced clinical tumour-node-metastasis stage, and a poor prognosis in patients with OTSCC. The in vitro assays indicated that the overexpression of Beclin-1 significantly inhibits the proliferation and clonogenicity of OTSCC cells. These results demonstrate that Beclin-1 acts as a tumour suppressor in the development or progression of OTSCC and that Beclin-1 may represent a novel prognostic marker for patients with OTSCC. D.A. Spandidos 2016-08 2016-06-23 /pmc/articles/PMC4940089/ /pubmed/27356955 http://dx.doi.org/10.3892/mmr.2016.5437 Text en Copyright: © Hu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Hu, Zedong Zhong, Zhaoming Huang, Shaohui Wen, Haojie Chen, Xue Chu, Hongying Li, Qiuli Sun, Chuanzheng |
spellingShingle |
Hu, Zedong Zhong, Zhaoming Huang, Shaohui Wen, Haojie Chen, Xue Chu, Hongying Li, Qiuli Sun, Chuanzheng Decreased expression of Beclin-1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma |
author_facet |
Hu, Zedong Zhong, Zhaoming Huang, Shaohui Wen, Haojie Chen, Xue Chu, Hongying Li, Qiuli Sun, Chuanzheng |
author_sort |
Hu, Zedong |
title |
Decreased expression of Beclin-1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma |
title_short |
Decreased expression of Beclin-1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma |
title_full |
Decreased expression of Beclin-1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma |
title_fullStr |
Decreased expression of Beclin-1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma |
title_full_unstemmed |
Decreased expression of Beclin-1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma |
title_sort |
decreased expression of beclin-1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma |
description |
The autophagy-related gene Beclin-1 is critical in the regulation of tumourigenesis and progression, but its role in oral tongue squamous cell carcinoma (OTSCC) has not yet been reported. This study aimed to investigate Beclin-1 expression and its significance in OTSCC. Beclin-1 expression was assessed by reverse transcription-quantitative polymerase chain reaction or western blot analysis in 14 OTSCC tissues and matched adjacent noncancerous tissues as well as in 5 OTSCC cell lines and a normal tongue epithelial cell line. Beclin-1 protein expression was examined by immunohistochemistry in 133 OTSCC specimens, and the correlation between Beclin-1 expression and clinicopathological features was investigated. Furthermore, MTT and colony formation assays were performed to investigate the effect of Beclin-1 on the proliferation and clonogenicity of OTSCC cells. It was demonstrated that Beclin-1 expression was significantly decreased in the majority of the 14 OTSCC tissues and the 5 OTSCC cell lines relative to the matched non-cancerous tissues and the normal tongue epithelial cell line, respectively. Immunohistochemistry analysis revealed that decreased Beclin-1 expression was significantly correlated with poor differentiation, lymph node metastasis, advanced clinical tumour-node-metastasis stage, and a poor prognosis in patients with OTSCC. The in vitro assays indicated that the overexpression of Beclin-1 significantly inhibits the proliferation and clonogenicity of OTSCC cells. These results demonstrate that Beclin-1 acts as a tumour suppressor in the development or progression of OTSCC and that Beclin-1 may represent a novel prognostic marker for patients with OTSCC. |
publisher |
D.A. Spandidos |
publishDate |
2016 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940089/ |
_version_ |
1613607121502339072 |